Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 16Cholangiocarcinoma 8Barrett Esophagus 6Thyroid Neoplasms 5Recurrence 5Pancreatic Neoplasms 5Liver Neoplasms 5Neoplasm Metastasis 4Lung Neoplasms 4Breast Neoplasms 4Thyroid Nodule 3Esophageal Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Thyroid Diseases 2Thyroid Cancer, Papillary 2Prostatic Neoplasms 2Pain 2Neoplasms 2Hyperaldosteronism 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Agnosia 2Squamous Intraepithelial Lesions 1Rectal Neoplasms 1Papillary Thyroid Microcarcinoma 1Pancreatic cancer, adult 1Pancreatic Neuroendocrine Tumors, WHO Grade I-II 1Neuroma 1Neuralgia 1

Interventions

entecavir 3polysaccharide MGN3 1lens intermediate filament proteins 1Tumor Necrosis Factor-alpha 1Tetanus Toxoid 1Rapid Diagnostic Tests 1Radiofrequency Ablation 1Polymorphism, Genetic 1Pneumococcal Vaccines 1Measles-Mumps-Rubella Vaccine 1Lamivudine 1Hypothermia, Induced 1Heptavalent Pneumococcal Conjugate Vaccine 1Hepatitis B Vaccines 1Enzyme-Linked Immunosorbent Assay 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hepatitis B × Radiofrequency Ablation × Clear all
NCT01018381 2009-11-23

Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection

The 108 Military Central Hospital

Phase NA Completed
130 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡